Page last updated: 2024-08-23

dehydrocorydalin and Breast Neoplasms

dehydrocorydalin has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, F; Huang, H; Huang, Y; Wang, S; Zheng, G1
Bao, J; Chen, L; Chen, X; Dang, Y; Fu, S; Huang, M; Wang, Y; Xu, Z1

Other Studies

2 other study(ies) available for dehydrocorydalin and Breast Neoplasms

ArticleYear
Dehydrocorydaline inhibits the tumorigenesis of breast cancer MDA‑MB‑231 cells.
    Molecular medicine reports, 2020, Volume: 22, Issue:1

    Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice; Mice, SCID

2020
Dehydrocorydaline inhibits breast cancer cells proliferation by inducing apoptosis in MCF-7 cells.
    The American journal of Chinese medicine, 2012, Volume: 40, Issue:1

    Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Corydalis; Cysteine Proteinase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Humans; Membrane Potential, Mitochondrial; Oligopeptides; Phytotherapy; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2

2012